BH1-DM1

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameBH1-DM1
Drug Alias NameBH1-DM1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > DM1 payload
Mechanisms of ActionAnti-CD276Tubulin polymerisation inhibitors
TargetsCD276 antigenTubulin
Therapy Area/IndicationsEsophageal Squamous Cell Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe University Of Hong Kong-Shenzhen Hospital
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Hong Kong-Shenzhen Hospital
Inactive CompaniesN/A
Active IndicationsEsophageal Squamous Cell Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A